Optometry News

Every medical innovation is usually met with both some excitement and some appropriate skepticism.

GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, according to a study published in Ophthalmology Retina.

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, according to a press release.

The FDA approved Epioxa for the treatment of keratoconus, Glaukos announced in a press release.

ORLANDO — At 12 months, AURN001, an allogenic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, achieved all primary and secondary endpoints in the phase 1/2 CLARA trial, according to a presenter.

ORLANDO — Drugs commonly used in cancer immunotherapy carry the risk for ocular adverse events, according to a speaker.

ORLANDO — Social determinants of health affect whether a patient undergoes cross-linking or transplantation for keratoconus, according to a study.

ORLANDO —The need for enhancement procedures after SMILE is rare, but surgeons need to consider the advantages and disadvantages of each option, according to a speaker here.

ORLANDO — Dehydrated corneas were noninferior to standard donor corneas for deep anterior lamellar keratoplasty, according to a study.